These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7955188)

  • 41. Low-energy endocardial defibrillation using an axillary or a pectoral thoracic electrode location.
    Saksena S; DeGroot P; Krol RB; Raju R; Mathew P; Mehra R
    Circulation; 1993 Dec; 88(6):2655-60. PubMed ID: 8252676
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of shock waveform configuration on the defibrillation capacity of implantable cardioverter defibrillators in dogs.
    Pariaut R; Saelinger C; Vila J; Deforge W; Queiroz-Williams P; Beaufrère H; Zimmerman M; Saile K; Reynolds CA
    J Vet Cardiol; 2012 Sep; 14(3):389-98. PubMed ID: 22819488
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Automatic determination of timing intervals for upper limit of vulnerability using ICD electrograms.
    Shehata M; Belk P; Kremers M; Saba S; Cao J; Swerdlow CD
    Pacing Clin Electrophysiol; 2008 Jun; 31(6):691-700. PubMed ID: 18507541
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intracardiac emergency defibrillation for refractory ventricular fibrillation during implantation of cardioverter defibrillators with nonthoracotomy lead systems.
    Pitschner HF; Neuzner J
    Pacing Clin Electrophysiol; 1993 Feb; 16(2):291-6. PubMed ID: 8446519
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Upper limit of vulnerability during defibrillator implantations predicts the occurrence of appropriate shock therapy for ventricular fibrillation.
    Yamashita S; Yoshida A; Fukuzawa K; Fujiwara R; Suzuki A; Nakanishi T; Matsumoto A; Konishi H; Ichibori H; Hirata K
    Circ J; 2014; 78(7):1606-11. PubMed ID: 24817761
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of low-energy T wave shocks for induction of ventricular fibrillation in patients with implantable cardioverter defibrillators.
    Bhandari AK; Isber N; Estioko M; Ziccardi T; Cannom DS; Park Y; Lerman RD; Prejean C; Sun GW
    J Electrocardiol; 1998 Jan; 31(1):31-7. PubMed ID: 9533375
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of defibrillation threshold testing on heart failure hospitalization or death in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT).
    Aktas MK; Huang DT; Daubert JP; Schuger CD; McNitt S; Goldenberg I; Moss AJ; Zareba W
    Heart Rhythm; 2013 Feb; 10(2):193-9. PubMed ID: 23085128
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Initial clinical experience with endocardial defibrillation using an implantable cardioverter/defibrillator with a triple-electrode system.
    Saksena S; Tullo NG; Krol RB; Mauro AM
    Arch Intern Med; 1989 Oct; 149(10):2333-9. PubMed ID: 2802898
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Safety and efficacy of implantable defibrillator therapy with programmed shock energy at twice the augmented step-down defibrillation threshold: results of the prospective, randomized, multicenter Low-Energy Endotak Trial.
    Neuzner J; Liebrich A; Jung J; Himmrich E; Pitschner HF; Winter J; Vester EG; Michel U; Nisam S; Heisel A
    Am J Cardiol; 1999 Mar; 83(5B):34D-39D. PubMed ID: 10089837
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ventricular proarrhythmic effects of ventricular cycle length and shock strength in a sheep model of transvenous atrial defibrillation.
    Ayers GM; Alferness CA; Ilina M; Wagner DO; Sirokman WA; Adams JM; Griffin JC
    Circulation; 1994 Jan; 89(1):413-22. PubMed ID: 8281677
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transthoracic defibrillation of short-lasting ventricular fibrillation: a randomised trial for comparison of the efficacy of low-energy biphasic rectilinear and monophasic damped sine shocks.
    Szili-Torok T; Theuns D; Verblaauw T; Scholten M; Kimman GJ; Res J; Jordaens L
    Acta Cardiol; 2002 Oct; 57(5):329-34. PubMed ID: 12405569
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assessment of Efficacy and Necessity of Routine Defibrillation Threshold Testing in Patients Undergoing Implantable Cardioverter-Defibrillator (ICD) Implantation.
    Ashino S; Nakai T; Sonoda K; Sasaki N; Kurokawa S; Ikeya Y; Okumura Y; Ohkubo K; Kunimoto S; Watanabe I; Hirayama A
    Int Heart J; 2015; 56(6):618-21. PubMed ID: 26549282
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relationship between shock energy and postdefibrillation ventricular arrhythmias in patients with implantable defibrillators.
    Zivin A; Souza J; Pelosi F; Flemming M; Knight BP; Goyal R; Morady F; Strickberger SA
    J Cardiovasc Electrophysiol; 1999 Mar; 10(3):370-7. PubMed ID: 10210500
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transvenous biventricular defibrillation.
    Meisel E; Butter C; Philippon F; Higgins S; Strickberger SA; Smith J; Hahn S; Michel U; Schubert B; Pfeiffer D
    Am J Cardiol; 2000 Nov; 86(9A):76K-85K. PubMed ID: 11084104
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Low-energy endocardial defibrillation using dual, triple, and quadruple electrode systems.
    Munsif AN; Saksena S; DeGroot P; Krol RB; Matthew P; Giorgberidze I; Kaushik RR; Mehra R
    Am J Cardiol; 1997 Jun; 79(12):1632-9. PubMed ID: 9202354
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multicenter comparison of truncated biphasic shocks and standard damped sine wave monophasic shocks for transthoracic ventricular defibrillation. Transthoracic Investigators.
    Bardy GH; Marchlinski FE; Sharma AD; Worley SJ; Luceri RM; Yee R; Halperin BD; Fellows CL; Ahern TS; Chilson DA; Packer DL; Wilber DJ; Mattioni TA; Reddy R; Kronmal RA; Lazzara R
    Circulation; 1996 Nov; 94(10):2507-14. PubMed ID: 8921795
    [TBL] [Abstract][Full Text] [Related]  

  • 57. ICD Shock, Not Ventricular Fibrillation, Causes Elevation of High Sensitive Troponin T after Defibrillation Threshold Testing--The Prospective, Randomized, Multicentre TropShock-Trial.
    Semmler V; Biermann J; Haller B; Jilek C; Sarafoff N; Lennerz C; Vrazic H; Zrenner B; Asbach S; Kolb C
    PLoS One; 2015; 10(7):e0131570. PubMed ID: 26208329
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cardioverter defibrillator implantation without induction of ventricular fibrillation: a single-blind, non-inferiority, randomised controlled trial (SIMPLE).
    Healey JS; Hohnloser SH; Glikson M; Neuzner J; Mabo P; Vinolas X; Kautzner J; O'Hara G; VanErven L; Gadler F; Pogue J; Appl U; Gilkerson J; Pochet T; Stein KM; Merkely B; Chrolavicius S; Meeks B; Foldesi C; Thibault B; Connolly SJ;
    Lancet; 2015 Feb; 385(9970):785-91. PubMed ID: 25715991
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Myocardial vulnerability to T wave shocks: relation to shock strength, shock coupling interval, and dispersion of ventricular repolarization.
    Fabritz CL; Kirchhof PF; Behrens S; Zabel M; Franz MR
    J Cardiovasc Electrophysiol; 1996 Mar; 7(3):231-42. PubMed ID: 8867297
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of rapid pacing and T-wave scanning on the relation between the defibrillation and upper-limit-of-vulnerability dose-response curves.
    Malkin RA; Idriss SF; Walker RG; Ideker RE
    Circulation; 1995 Sep; 92(5):1291-9. PubMed ID: 7648678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.